Healthcare and Life Science
First product incorporating Arecor’s Arestat Technology, AT220, launches in Europe
First commercial sale triggers milestone payment and future royalties to Arecor
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space. This has been driven by several factors, including the lack of long-term data, the imbalance of upside and downside risk between manufacturers and payers, and d...
A longitudinal perspective on innovation
There is growing interest in the innovation process in the biopharmaceutical industry, with particular public scrutiny around the composition of research and development (R&D) spending and the role of intellectual property. This process is commonly characterized as involving a mixtu...
Oncology vaccines: Are they positioned for PMA success?
With combinations taking center stage following the initial influx of immune checkpoint inhibitor monotherapies, the authors look ahead to the potential of mRNA vaccines in oncology and describe the pricing and market access opportunities and challenges that may await current and future...
The burden of non-specific pain disorder in US women
Based on existing evidence on the delay, lack of recognition, and burden of pain conditions commonly afflicting women (specifically endometriosis, PCOS, fibromyalgia, IBS or migraines), CRA sought to understand how being diagnosed with these conditions impacts women’s mental health and ...
The longitudinal history of medicines innovation: Part two
The second of a two-part article, CRA’s Life Sciences Practice team, along with experts at The Janssen Pharmaceutical Companies of Johnson & Johnson, recently conducted a landscape review of how complex pharmaceutical innovation happens in practice, leveraging three therapy area cas...
The longitudinal history of medicines innovation: Part One
This article is originally published in PharmaPhorum. As we move forwards in public discussions on pharmaceutical innovation and its value to patients and society, it is helpful to ground conversations in a solid understanding of how medicines development occurs. ...
High accuracy sample positioner now offers up to 800 µm travel
Queensgate’s NanoScan SP800 nanopositioning sample scanner offers high-accuracy positioning performance for longer ranges. ...
Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria
Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria ...
Prediabetes: tips for preventing diabetes and improving health
14 of November is World Diabetes Day. It is estimated that 422 million people around the world are living with diabetes. ...